Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction
Clinical trial NCT05350969 · COMPLETED
Trial details
- NCT number
- NCT05350969
- Sponsor
- Cardior Pharmaceuticals GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-07
- Primary completion
- 2024-09-26
- Enrollment
- 294
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.